BIO-Europe® 2012 Press Releases
News for BIO-Europe® 2012 will be available soon
November 14, 2011BIO-Europe® 2011 accelerates partnering in the life science industry Life science dealmakers from around the world engaged in thousands of partnering meetings and shared insights on strategies for building new and productive partnerships at BIO-Europe® 2011, Europe's largest partnering conference, held October 31–November 2 at the CCD Congress Center in Duesseldorf, Germany. "BIO-Europe was once again the defining partnering industry event...more ►
October 12, 2011BIO-Europe® 2011 workshop to discover which biotech "has talent" Promising biotechs will have a unique opportunity to pitch their best assets to a star-studded panel of business development executives in a special competition at BIO-Europe® 2011, being held October 31–November 2 at the CCD Congress Center in Duesseldorf, Germany. In the workshop, "The Perfect Pitch: Biotech Has Talent," attendees will have a chance to win a one-to-one ...more ►
October 6, 2011BIO-Europe® 2011 program to highlight non-traditional partnerships and the year's transformational deals Non-traditional healthcare alliances and the year's prominent transformational deals will be the topics of in-depth discussion in the opening and keynote plenary sessions at BIO-Europe® 2011, being held October 31–November 2 at the CCD Congress Center in Duesseldorf, Germany. In the opening plenary session, "Non-traditional Partnerships in the New Healthcare Ecosystem," mo...more ►
September 19, 2011World leaders in the life science industry to gather in Duesseldorf for the 17th annual BIO-Europe® partnering conference From October 31 to November 2, the world's life science leaders and dealmakers will gather in Duesseldorf, Germany for BIO-Europe® 2011, Europe's largest partnering event serving the global biotechnology industry. Now in its seventeenth year, the three-day conference will host more than 3,000 attendees representing about 1,800 companies who will engage in more than 15,000 one-to-o...more ►
Latest headlines from partneringNEWS™
1 May 2012 Epizyme: Intensive dealmaking in pursuit of personalized therapeutics Little was known about the branch of epigenetics called histone methyltransferases (HMTs) when Epizyme began in late 2007. Yet before the company presented the world's first animal demonstration of efficacy for HMTs in July 2011, it had already attracted USD 54 million in venture investment and USD 45 million in funding from two pharma partners and two foundations. more ►
11 April 2012 Inova Software: Structuring business development to align with strategy Opportunities for acquiring external assets may move faster than an internal BD group can react. Inova supports a capability to be both fast and nimble in the hunt for novel assets from scouting through to licensing and beyond to alliance management. more ►
25 March 2012 GSK, J&J back USD 200 million fund for early stage assets The chairmen of Johnson & Johnson Pharmaceuticals and GlaxoSmithKline R&D announced a trailblazing venture fund for fast-tracking early stage assets during the closing plenary session at BIO-Europe Spring® in Amsterdam. more ►
25 March 2012 Investors more confident, but selective with biotechs The biotech sector continues to outperform other industries in public equity markets in the United States, but private equity is more selective about opportunities, according to Biotechnology Industry Organization (BIO). more ►
22 March 2012 Examining major deals of 2011 with the real dealmakers Lead executives with four of the headline-grabbing deals of the past year shared insights into the negotiation with participants at BIO-Europe Spring® in Amsterdam. more ►
